Cue Biopharma (CUE) Stock Chart & Stock Price History $0.67 -0.04 (-5.34%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cue Biopharma Stock Price Performance The Cue Biopharma (CUE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.48%, with a year-to-date return of -38.57%. In the past month, the stock has decreased 14.29%, reflecting recent market activity. As of the latest close, Cue Biopharma traded at $0.67 with a market cap of $50.45 million and volume of 159,462 shares. Five years ago, the stock traded at $30.54, representing a 97.81% decrease over that period. At the time, it had a market cap of $814.52 million and a volume of 515,266 shares. Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.63%1 Month Performance-14.29%3 Month Performance-49.27%Year-To-Date Performance-38.57%1 Year Performance-64.48%5 Year Performance-97.81% CUE Stock Chart for Wednesday, May, 21, 2025 CUE Chart by TradingView Cue Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025$0.71$0.67-5.34%$0.72$0.66159,462 shs$50.45 million05/19/2025$0.72$0.71-2.41%$0.74$0.69140,884 shs$53.30 million05/16/2025$0.72$0.72+0.15%$0.75$0.72120,373 shs$44.81 million05/15/2025$0.75$0.72-2.86%$0.75$0.7085,098 shs$44.75 million05/14/2025$0.77$0.75-2.97%$0.77$0.74106,590 shs$46.06 million05/13/2025$0.75$0.77+2.25%$0.77$0.68274,254 shs$47.47 million05/12/2025$0.78$0.75-3.72%$0.78$0.75159,546 shs$46.43 million05/09/2025$0.77$0.78+1.04%$0.78$0.7594,813 shs$48.22 million05/08/2025$0.76$0.77+1.85%$0.78$0.7658,233 shs$47.72 million05/07/2025$0.75$0.76+1.04%$0.78$0.74135,553 shs$46.86 million Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/06/2025$0.78$0.75-3.60%$0.77$0.71176,367 shs$46.38 million05/05/2025$0.75$0.78+3.40%$0.79$0.7586,161 shs$48.11 million05/02/2025$0.75$0.75+0.11%$0.80$0.7471,095 shs$46.53 million05/01/2025$0.76$0.75-0.44%$0.79$0.7448,893 shs$46.48 million04/30/2025$0.76$0.76-1.24%$0.79$0.73133,131 shs$46.68 million04/29/2025$0.79$0.76-3.23%$0.86$0.7688,763 shs$47.27 million04/28/2025$0.79$0.79+0.64%$0.81$0.7816,217 shs$48.84 million04/25/2025$0.86$0.79-8.35%$0.86$0.78135,495 shs$48.53 million04/24/2025$0.84$0.86+2.43%$0.86$0.80143,380 shs$52.95 million04/23/2025$0.78$0.84+6.85%$0.85$0.75327,586 shs$51.70 million04/22/2025$0.78$0.78+0.19%$0.83$0.75143,369 shs$48.39 million04/21/2025$0.76$0.78+2.52%$0.80$0.74131,833 shs$48.29 million Related Companies Voyager Therapeutics Stock Price Chart Y-mAbs Therapeutics Stock Price Chart Inventiva Stock Price Chart Cardiff Oncology Stock Price Chart Prime Medicine Stock Price Chart INmune Bio Stock Price Chart Tiziana Life Sciences Stock Price Chart Molecular Partners Stock Price Chart Eledon Pharmaceuticals Stock Price Chart CytomX Therapeutics Stock Price Chart Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CUE) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
